About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RISE With Residents | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05490121

RISE With Residents

Prevention of child maltreatment (CM) remains a public health priority in Canada; approximately one-third of Canadians report exposure to at least one form of CM. Physicians play an important role in ...

Lead sponsor: McMaster University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

McMaster University

Collaborators

Royal College of Physicians and Surgeons of Canada

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Participant is a resident at a Canadian University.
•Participant is fluent in written and spoken English.

Exclusion Criteria

•Participant has previously accessed VEGA intervention materials.
•Participant is currently enrolled in or plans to enroll in any other educational intervention focused on family violence within the study time period (approximately next 3 months).

Related studies

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

NCT06956781 · PTSD, Trauma, and more

Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

NCT06867289 · Procedural Sedation and Analgesia, Pediatric ALL

RECRUITINGPhase 1

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more

RECRUITINGPhase 1/2

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

NCT03938987 · Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, and more

HIIT in Youth With Congenital Heart Disease (MedBIKE)

NCT04575883 · Congenital Heart Disease, Pediatric ALL

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 23, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment71

Start dateAug 2022

Last updatedSep 23, 2025

Condition

Domestic Violence Child Maltreatment Pediatric ALL Psychiatry Education, Medical, Graduate

Locations shown

McMaster University

Hamilton, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 23, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions